17218-Ovarian Cancer-NA-858

Ovarian Cancer

3000-03-005/ENGOT-OV44 : A RANDOMIZED, DOUBLE-BLIND, PHASE 3 COMPARISON OF PLATINUM-BASED THERAPY WITH TSR-042 AND NIRAPARIB VERSUS STANDARD OF CARE PLATINUM-BASED THERAPY AS FIRST-LINE TREATMENT OF STAGE III OR IV NONMUCINOUS EPITHELIAL OVARIAN CANCER

  • Details

ClinicalTrials.gov ID: NCT03602859
Diagnosis Type: NA
USOR Number: 17218

  • Address

10197 N 92nd St, Suite 101
Scottsdale, AZ 85258
P: (480) 993-2950

Find a Clinical Trial

Search by practice name, trial titles, indicators and specific disease types.